BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19752368)

  • 1. Donor serum SMARCAL1 concentrations predict primary graft dysfunction in cardiac transplantation.
    Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Aliabadi A; Zuckermann A; Krenn K; Grimm M
    Circulation; 2009 Sep; 120(11 Suppl):S198-205. PubMed ID: 19752368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor myocardial apollon mRNA is associated with cardiac allograft rejection.
    Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Aliabadi A; Zuckermann A; Grimm M
    J Heart Lung Transplant; 2010 Jul; 29(7):777-85. PubMed ID: 20462770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation.
    Khush KK; Menza RL; Babcock WD; Zaroff JG
    J Heart Lung Transplant; 2007 Oct; 26(10):1048-53. PubMed ID: 17919626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation.
    Oto T; Excell L; Griffiths AP; Levvey BJ; Snell GI
    J Heart Lung Transplant; 2008 Jan; 27(1):78-85. PubMed ID: 18187091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction.
    Szarszoi O; Besik J; Smetana M; Maly J; Urban M; Maluskova J; Lodererova A; Hoskova L; Tucanova Z; Pirk J; Netuka I
    Physiol Res; 2016 Jun; 65(2):251-7. PubMed ID: 26447521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation.
    Santise G; D'Ancona G; Falletta C; Pirone F; Sciacca S; Turrisi M; Biondo D; Pilato M
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):476-9. PubMed ID: 19564203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients.
    Boccheciampe N; Audibert G; Rangeard O; Charpentier C; Perrier JF; Lalot JM; Voltz C; Strub P; Loos-Ayav C; Meistelman C; Mertes PM; Longrois D
    Int J Cardiol; 2009 Mar; 133(1):80-6. PubMed ID: 18255177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation.
    Méndez AB; Ordonez-Llanos J; Mirabet S; Galan J; Maestre ML; Brossa V; Rivilla MT; López L; Koller T; Sionis A; Roig E
    Transplant Proc; 2016 Nov; 48(9):3021-3023. PubMed ID: 27932136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.
    Avtaar Singh SS; DAS DE S; Rushton S; Berry C; Al-Attar N
    J Card Fail; 2019 Dec; 25(12):971-977. PubMed ID: 31330297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.
    Lozano-Edo S; Sánchez-Lázaro I; Portolés M; Roselló-Lletí E; Tarazón E; Arnau-Vives MA; Ezzitouny M; Lopez-Vilella R; Almenar-Bonet L; Martínez-Dolz L
    Transplantation; 2022 Apr; 106(4):887-893. PubMed ID: 33901112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
    Kobashigawa J; Zuckermann A; Macdonald P; Leprince P; Esmailian F; Luu M; Mancini D; Patel J; Razi R; Reichenspurner H; Russell S; Segovia J; Smedira N; Stehlik J; Wagner F;
    J Heart Lung Transplant; 2014 Apr; 33(4):327-40. PubMed ID: 24661451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twinned single-lung transplantation: a privileged model for the study of recipient-dependent factors of outcome.
    Olland A; Santelmo N; Orsini B; Falcoz PE; Dorent R; Mal H; Thomas P; Massard G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1357-64; discussion 1364-5. PubMed ID: 22241010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin 8 concentrations in donor bronchoalveolar lavage: impact on primary graft failure in double lung transplant].
    Almenar M; Cerón J; Gómez MA; Peñalver JC; Jiménez MA; Padilla J
    Arch Bronconeumol; 2009 Jan; 45(1):12-5. PubMed ID: 19186293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
    Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival.
    Bermudez CA; Adusumilli PS; McCurry KR; Zaldonis D; Crespo MM; Pilewski JM; Toyoda Y
    Ann Thorac Surg; 2009 Mar; 87(3):854-60. PubMed ID: 19231405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of the anhepatic phase during liver transplantation.
    Ijtsma AJ; van der Hilst CS; de Boer MT; de Jong KP; Peeters PM; Porte RJ; Slooff MJ
    Liver Transpl; 2009 Sep; 15(9):1050-5. PubMed ID: 19718649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.
    Dronavalli VB; Rogers CA; Banner NR
    Transplantation; 2015 Sep; 99(9):1919-25. PubMed ID: 25742423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
    Weiss ES; Allen JG; Patel ND; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circ Heart Fail; 2009 Sep; 2(5):401-8. PubMed ID: 19808369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.